Agilent Technologies (NYSE:A) Lowered to Hold Rating by StockNews.com

Agilent Technologies (NYSE:A) was downgraded by equities researchers at StockNews.com from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Tuesday.

Other equities analysts have also recently issued reports about the stock. Stifel Nicolaus reaffirmed a “buy” rating and issued a $151.00 target price on shares of Agilent Technologies in a report on Monday, August 26th. UBS Group upped their target price on shares of Agilent Technologies from $141.00 to $150.00 and gave the company a “neutral” rating in a report on Thursday, August 22nd. Citigroup increased their target price on shares of Agilent Technologies from $150.00 to $165.00 and gave the stock a “buy” rating in a research note on Thursday, August 22nd. Evercore ISI upped their price objective on Agilent Technologies from $135.00 to $145.00 and gave the company an “in-line” rating in a research note on Tuesday, October 1st. Finally, Barclays lifted their target price on Agilent Technologies from $135.00 to $145.00 and gave the company an “underweight” rating in a research note on Tuesday, October 15th. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and eight have issued a buy rating to the stock. Based on data from MarketBeat, Agilent Technologies currently has a consensus rating of “Hold” and an average price target of $143.40.

Agilent Technologies Trading Up 2.8 %

NYSE:A opened at $138.11 on Tuesday. The company has a market capitalization of $39.68 billion, a PE ratio of 31.25, a P/E/G ratio of 5.91 and a beta of 1.07. Agilent Technologies has a 52-week low of $124.10 and a 52-week high of $155.35. The stock’s 50 day moving average price is $137.72 and its 200 day moving average price is $137.43. The company has a quick ratio of 1.37, a current ratio of 1.78 and a debt-to-equity ratio of 0.36.

Insiders Place Their Bets

In related news, SVP Dominique Grau sold 9,990 shares of the firm’s stock in a transaction that occurred on Thursday, September 26th. The stock was sold at an average price of $145.00, for a total value of $1,448,550.00. Following the completion of the transaction, the senior vice president now directly owns 40,011 shares of the company’s stock, valued at $5,801,595. This trade represents a 19.98 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.

Institutional Trading of Agilent Technologies

Several large investors have recently bought and sold shares of the company. Livelsberger Financial Advisory purchased a new position in shares of Agilent Technologies during the 3rd quarter worth approximately $28,000. Crewe Advisors LLC increased its position in Agilent Technologies by 114.8% during the second quarter. Crewe Advisors LLC now owns 189 shares of the medical research company’s stock worth $25,000 after buying an additional 101 shares in the last quarter. Ashton Thomas Securities LLC acquired a new position in shares of Agilent Technologies in the third quarter worth $31,000. Ridgewood Investments LLC purchased a new stake in shares of Agilent Technologies in the second quarter valued at $29,000. Finally, Fortitude Family Office LLC boosted its stake in shares of Agilent Technologies by 68.3% during the third quarter. Fortitude Family Office LLC now owns 234 shares of the medical research company’s stock valued at $35,000 after acquiring an additional 95 shares during the last quarter.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.